ARCHIVES

ODAC Member Critical Of Amgen For Price Incentives.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

Obey Attacks NCI, Eppley, Shubick, Asks for Full Report From GAO

June 10, 1977

FDA Approves Lymphoseek For Imaging Lymph Nodes

March 29, 2013

Study Uncovers New Mechanism In Class of Chemotherapy Drugs

November 30, 2012

XIIIth International Cancer Congress in Seattle Drawing Record Numbers Or Top Scientific Program

July 30, 1982

Centers: Bookman Leaves Fox Chase for Arizona

September 11, 2009

CMS Removes Obstacles for Contractors to Deny EPO Coverage for Cancer Anemia.

March 9, 2007